Acupuncture Based on Regulating Autonomic Nerves for the Prevention of Migraine Without Aura: A Prospective, Double-Dummy, Randomized Controlled Clinical Trial

Chuanlong Zhou, Jie Bao, Hantong Hu, Siting Ye, Xiaomei Shao, Yi Liang, Jianqiao Fang, Chuanlong Zhou, Jie Bao, Hantong Hu, Siting Ye, Xiaomei Shao, Yi Liang, Jianqiao Fang

Abstract

Background: Migraine without aura (MWoA) is a nervous system disease, which is closely related to autonomic nerves dysfunction. As a popular non-pharmacological alternative treatment for preventing migraine, it remains unclear whether the acupuncture can prevent MWoA. Thus, this trial aims to evaluate the preventive effect and safety of the acupuncture method of stimulating acupoints that regulate autonomic nerves in MWoA patients.

Methods: This is a single-center, prospective, double-dummy, randomized controlled clinical trial. A total of ninety-six patients with MWoA are randomly allocated to acupuncture combined with the placebo group and sham acupuncture combined with the medication group in a 1:1 ratio. All subjects will receive intervention for 8 weeks and follow-up assessments three times (one month, three months, and six months in follow-up visiting). The frequency of acupuncture in both groups is three times a week for eight weeks. The primary outcome will be evaluated using a visual analog scale (VAS) and the number of migraine attacks per four weeks. The secondary outcome measures will include the migraine-specific quality of life (MSQOL) scale and headache needs assessment survey (HANA) questionnaire scale.

Results: The acupoint selection of this clinical trial is based on the combination of traditional Chinese medicine theory with modern medicine, thereby evaluating the efficacy and safety of the acupuncture method of stimulating acupoints that regulate autonomic nerves in the prevention of MWoA. The results may provide evidence of the beneficial effects of acupuncture on the prevention of MWoA by regulating autonomic nerves dysfunction.

Trial registration: ClinicalTrials.gov NCT04766762.

Keywords: acupuncture; autonomic nerves; migraine without aura; protocol; randomized controlled clinical trial.

Conflict of interest statement

The authors declare that they have no conflicts of interest in relation to this work.

© 2022 Zhou et al.

Figures

Figure 1
Figure 1
Study design flowchart.

References

    1. Silberstein SD. Migraine. Lancet. 2004;363(9406):381–391. doi:10.1016/S0140-6736(04
    1. Natoli J, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2009:599–609. doi:10.1111/j.1468-2982.2009.01941.x
    1. Stovner LJ, Hagen K. Prevalence, burden, and cost of headache disorders. Curr Opin Neurol. 2006;19(3):281–285. doi:10.1097/01.wco.0000227039.16071.92
    1. Kincses ZT, Vereb D, Farago P, et al. Are Migraine With and Without Aura Really Different Entities? Front Neurol. 2019;10:982. doi:10.3389/fneur.2019.00982
    1. Headache Classification Committee of the International Headache Society (IHS); The International Classification of Headache Disorders. Cephalalgia. 2018;38(1):1–211. doi:10.1177/0333102417738202
    1. Shechter AL, Silberstein SD, Stewart WF, et al. Migraine and autonomic nervous system function: a population-based, case-control study. Neurology. 2002;58(3):422–427. doi:10.1212/wnl.58.3.422
    1. Goadsby PJ, Holland PR, Martins-Oliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017. doi:10.1152/physrev.00034.2015
    1. Miglis MG. Migraine and autonomic dysfunction: which is the horse and which is the jockey? Curr Pain Headache Rep. 2018;22(3):1–7. doi:10.1007/s11916-018-0671-y
    1. Qubty W, Patniyot I. Migraine pathophysiology. Pediatr Neurol. 2020;107:1–6. doi:10.1016/j.pediatrneurol.2019.12.014
    1. Gass JJ, Glaros AG. Autonomic dysregulation in headache patients. Appl Psychophysiol Biofeedback. 2013;38(4):257–263. doi:10.1007/s10484-013-9231-8
    1. Sarchielli P, Granella F, Prudenzano MP, et al. Italian guidelines for primary headaches: 2012 revised version. j Headache Pain. 2012;13(2):31–70. doi:10.1007/s10484-013-9231-8
    1. Dekker F, Dieleman J, Neven AK, et al. Preventive treatment for migraine in primary care, a population-based study in the Netherlands. Cephalalgia. 2013;33(14):1170–1178. doi:10.1177/0333102413490343
    1. Han J-S. Acupuncture analgesia: areas of consensus and controversy. Pain. 2011;152(3):S41–S48. doi:10.1016/j.pain.2010.10.012
    1. Vickers AJ, Cronin AM, Maschino AC, et al. Acupuncture for chronic pain: individual patient data meta-analysis. Arch Intern Med. 2012;172(19):1444–1453. doi:10.1001/archinternmed.2012.3654
    1. Chuan-long Z, Jie B, Xiao-mei S, et al. Randomized controlled study of different acupoints selection principles based on autonomic nerve function in patients with migraine without aura. China J Traditional Chin Med Pharmacy. 2021;36(1):5.
    1. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16(1):87–101. doi:10.1016/0304-3959(83)90088-X
    1. Patrick DL, Hurst BC, Hughes J. Further development and testing of the migraine‐specific quality of life (MSQOL) measure. Headache. 2000;40(7):550–560. doi:10.1046/j.1526-4610.2000.00086.x
    1. Szabo S. The World Health Organisation Quality of life (WHOQOL) assessment instrument. Quality Pharmacoeconomics Clin Trials. 1996;355–362. doi:10.1016/0277-9536(95)00112-k
    1. Cramer JA, Silberstein SD, Winner P. Development and validation of the Headache Needs Assessment (HANA) survey. Headache. 2001;41(4):402–409. doi:10.1046/j.1526-4610.2001.111006402.x
    1. Bussone G, Cerbo R, Martucci N, et al. Alpha-Dihydroergocryptine in the prophylaxis of migraine: a multicenter double-blind study versus flunarizine. Headache. 1999;39(6):426–431. doi:10.1046/j.1526-4610.1999.3906426.x
    1. Urits I, Patel M, Putz ME, et al. Acupuncture and its role in the treatment of migraine headaches. Neurol Therapy. 2020;9(2):375–394. doi:10.1007/s40120-020-00216-1
    1. Qin C, Fanrong L, Hui Z, et al. Study on the classification and application of acupoints on acupuncture in treating migraine. Zhejiang J Traditional Chin Med. 2013;1:854.
    1. White A, Resch K, Chan J, et al. Acupuncture for episodic tension-type headache: a multicentre randomized controlled trial. Cephalalgia. 2000;20(7):632–637. doi:10.1111/j.1468-2982.2000.00097.x
    1. Bäcker M, Grossman P, Schneider J, et al. Acupuncture in migraine: investigation of autonomic effects. Clin J Pain. 2008;24(2):106–115. doi:10.1097/AJP.0b013e318159f95e
    1. Deping L, Anle H. Clinical observation on 100 cases of migraine treated by acupuncture at Tianrong Point. Zhejiang J Traditional Chin Med. 1995;1:856.
    1. Chuan-long Z, Jie B, Xiao-mei S, et al. Theoretical discussion of point Tianrong (SI17) for treating migraine China. J Traditional Chin Med Pharmacy. 2019;1(3):3.
    1. Dawei Y, Zhibin L, Daren Z, et al. Application Manual of Acupoint Anatomy. Vol. 10. Bafang Culture Enterprise Company; 2001.
    1. Weiquan J, Peigen K, Jiamei J, et al. Symmetry changing of MFV and BEAM were investigated in migraine without aura with Tianrong acupoint treatment. J Brain Nervous Dis. 2002;10(5):282–284.
    1. Miao Y, Wei S, Changchun W, et al. Effect of Needling PC6 on HRV of DCAN Patients. J Clin Acupuncture Moxibustion. 2019;35(5):3.
    1. Zeng -X-X, Bian Z-X, Wu T-X, et al. Traditional Chinese medicine syndrome distribution in chronic hepatitis B populations: a systematic review. Am J Chin Med. 2011;39(6):1061–1074.
    1. Preeti L, Magesh K, Rajkumar K, et al. Recurrent aphthous stomatitis. J Oral Maxillofacial Pathol. 2011;15(3):252–256. doi:10.4103/0973-029X.86669
    1. Liu B, Xu H, Ma R, et al. Effect of blinding with a new pragmatic placebo needle: a randomized controlled crossover study. Medicine. 2014;93:27. doi:10.1097/MD.0000000000000200
    1. Liu L. Acupuncture as prophylaxis for chronic migraine: a protocol for a single-blinded, double-dummy randomised controlled trial. BMJ open. 2018;8(5):e020653. doi:10.1136/bmjopen-2017-020653
    1. White P, Lewith G, Berman B, et al. Reviews of acupuncture for chronic neck pain: pitfalls in conducting systematic reviews. Rheumatology. 2002;41(11):1224–1231. doi:10.1093/rheumatology/41.11.1224
    1. White A, Filshie J, Cummings T. Clinical trials of acupuncture: consensus recommendations for optimal treatment, sham controls and blinding. Complement Ther Med. 2001;9(4):237–245. doi:10.1054/ctim.2001.0489
    1. Lundeberg T, Lund I, Näslund J, et al. The Emperors sham–wrong assumption that sham needling is sham. Acupuncture Med. 2008;26(4):239–242. doi:10.1136/aim.26.4.239
    1. Linde K, Niemann K, Meissner K. Are sham acupuncture interventions more effective than (other) placebos? A re-analysis of data from the Cochrane review on placebo effects. Complementary Med Res. 2010;17(5):259–264. doi:10.1159/000320374
    1. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Sys Rev. 2004;1(2):847. doi:10.1002/14651858.CD003974.pub2
    1. Zhang CS, Tan HY, Zhang GS, et al. Placebo devices as effective control methods in acupuncture clinical trials: a systematic review. PLoS One. 2015;10(11):e0140825. doi:10.1371/journal.pone.0140825
    1. Dincer F, Linde K. Sham interventions in randomized clinical trials of acupuncture - review. Complement Ther Med. 2003;11(4):235–242. doi:10.1016/s0965-2299(03
    1. Lund I, Näslund J, Lundeberg T. Minimal acupuncture is not a valid placebo control in randomised controlled trials of acupuncture: a physiologist’s perspective. Chin Med. 2009;4(1):1–9. doi:10.1186/1749-8546-4-1

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться